Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
12/22/2010 | CN101919803A Controlled release preparation |
12/22/2010 | CN101919799A Novel sustained-release transdermal medicament delivery system |
12/22/2010 | CN101474411B Anti-tumor prodrug using novel amphipathic hyperbranched polyesters as carrier and preparation method |
12/22/2010 | CN101455641B Anti-cancer medicine liposome preparation sensitive to ray |
12/22/2010 | CN101336915B Medicine combination with antitumor activity |
12/21/2010 | US7855278 antibodies which induces the death of a cell that expresses Stra6 polypeptide; used to prevent or slow down (lessen) the development, growth, or spread of tumor characterized by the overexpression of a PRO10282 polypeptide; chemotherapy |
12/21/2010 | US7855184 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseases |
12/21/2010 | US7855183 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
12/21/2010 | US7855075 Methods of controlling proliferation and differentiation of stem and progenitor cells |
12/21/2010 | US7854935 Herbal therapy for the treatment of asthma |
12/21/2010 | US7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
12/21/2010 | US7854922 Skin preparation for external use characterized by containing sugar derivative of α, α-trehalose |
12/21/2010 | US7854753 to cellular surfaces without damage; transdermal, transmembrane; with solvent, gelling agent, and photocatalyst has a band gap energy of 2.9 eV to 3.2 e |
12/21/2010 | US7854717 uses ultrapheresis, refined to remove compounds of less than 120,000 daltons molecular weight, followed by administration of replacement fluid, to stimulate the patient's immune system to attack solid tumors |
12/21/2010 | CA2477885C Pressurised metered dose inhalers containing solutions of beta-2 agonists |
12/21/2010 | CA2464130C Mch antagonists for the treatment of obesity |
12/21/2010 | CA2453823C Dermal therapy using phosphate derivatives of electron transfer agents |
12/21/2010 | CA2444395C Use of nk-1 receptor antagonists against benign prostatic hyperplasia |
12/21/2010 | CA2404594C Agent for prophylaxis and treatment of renal disease |
12/21/2010 | CA2388595C Methods and devices for identifying patterns in biological systems and methods for uses thereof |
12/21/2010 | CA2369895C High affinity inhibitors for target validation and uses thereof |
12/21/2010 | CA2294924C Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
12/21/2010 | CA2267069C Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
12/21/2010 | CA2220753C Novel peptides and compositions which modulate apoptosis |
12/21/2010 | CA2214406C Use of penciclovir for the treatment of human herpes-virus-8 |
12/16/2010 | WO2010143661A1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity |
12/16/2010 | WO2010143101A1 Use of 1,25-dihydroxyvitamine d3 glycoside in lactating animals. |
12/16/2010 | WO2010143053A1 Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders |
12/16/2010 | WO2010142925A1 Use of alkylglycerols for preparing drugs |
12/16/2010 | WO2010111136A3 Aliskiren modulation of neurogenesis |
12/16/2010 | US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties |
12/16/2010 | US20100317109 Factor |
12/16/2010 | US20100317003 Novel compositions and methods in cancer with altered expression of kcnj9 |
12/16/2010 | US20100316768 Nutritionally Fortified Liquid Composition With Added Value Delivery Systems/Elements/Additives |
12/16/2010 | US20100316708 Novel Pharmaceutical Formulation Containing A Biguanide and a Thiazolidinedione Derivative |
12/16/2010 | US20100316703 Rna interference mediating small rna molecules |
12/16/2010 | US20100316652 Vascular endothelial cell growth factor antagonists |
12/16/2010 | US20100316610 Mutant having uracil phosphoribosyl transferase activity |
12/16/2010 | DE102009024542A1 Zusammensetzungen auf Basis von Chitosan-Oligosacchariden Compositions based on chitosan-oligosaccharides |
12/16/2010 | DE102009019460A1 Use of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor for treatment and/or prevention of coxsackievirus infection and adenoviral infection or diseases caused by coxsackievirus and/or adenovirus e.g. myocarditis and pericarditis |
12/16/2010 | CA2764782A1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity |
12/15/2010 | EP2261331A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis |
12/15/2010 | EP2261323A1 Feline probiotic lactobacilli |
12/15/2010 | EP2261322A1 Methods of use of probiotic bifidobacteria for companion animals |
12/15/2010 | EP2261321A1 Canine probiotic lactobacilli |
12/15/2010 | EP2261320A1 Canine probiotic lactobacilli |
12/15/2010 | EP2261319A1 Canine probiotic lactobacilli |
12/15/2010 | EP2261256A2 Methods of inhibiting metastasis |
12/15/2010 | EP2260870A2 Treatment of infectious diseases with combinations of a thioxanthene derivative with an anti-infective agent |
12/15/2010 | EP2260869A2 Pharmaceutical product |
12/15/2010 | EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents |
12/15/2010 | EP2260850A2 A2A receptor antogonists for use in the treatment of movement disorders |
12/15/2010 | EP2260846A1 Novel methods for the treatment of cancer |
12/15/2010 | EP2260845A2 Use of polyphenols for the treatment of alopecia |
12/15/2010 | EP2260844A1 Combination of an NMDA Receptor Antagonist and a Selective Serotonin Reuptake Inhibitor for the Treatment of Depression and other Mood Disorders |
12/15/2010 | EP2260842A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass |
12/15/2010 | EP2260838A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
12/15/2010 | EP2260837A1 Pharmaceutical compositions for the coordinated delivery of NSAIDs |
12/15/2010 | EP2260833A2 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic |
12/15/2010 | EP2259844A1 Compositions and methods for mucositis and oncology therapies |
12/15/2010 | EP2259800A1 Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
12/15/2010 | EP2259799A1 Combination of immunomodulator and anti-pathogenic agent |
12/15/2010 | EP2259782A1 Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders |
12/15/2010 | EP2259677A2 Systemic purine administration:modulating axonal outgrowth of central nervous system neurons |
12/15/2010 | EP1827495B1 Painkilling association comprising a dihydroimidazopyrazine derivative |
12/15/2010 | EP1720610B1 Alcohol metabolism moderating composition |
12/15/2010 | EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
12/15/2010 | EP1444523B1 Screening for hepatitis c virus entry inhibitors |
12/15/2010 | EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof |
12/15/2010 | EP1404174B1 Anti-infective compositions for treating disordered tissue such as cold sores |
12/15/2010 | EP1395289B1 Treatment of neuropathic pain with a n-methyl-d-aspartate (nmda) receptor antagonists |
12/15/2010 | EP1076703B2 Therapeutic uses of il-17 homologous polypeptides |
12/15/2010 | CN1956720B Combination medication for treating HIV infection |
12/15/2010 | CN1956716B Medicine capable of inhibiting activation of transcription factor KLF5 |
12/15/2010 | CN1935134B Combination comprising combretastatin and anticancer agents |
12/15/2010 | CN1933840B Use of a phenothiazine derivative for preventing and/or treating hearing loss |
12/15/2010 | CN1916009B Process for preparing amine platinum complexes |
12/15/2010 | CN1915429B Combinations of the peroxisome proliferator-activated receptor (ppar) activator and sterol absorption inhibitor |
12/15/2010 | CN1883456B Flavor-hidden pharmaceutical granule, preparation method and use thereof |
12/15/2010 | CN1665932B Vectors with modified protease-dependent tropism |
12/15/2010 | CN1547475B Dermal therapy using phosphate derivatives of electron transfer agents |
12/15/2010 | CN101918031A Skin external preparation |
12/15/2010 | CN101917990A Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
12/15/2010 | CN101917983A Composition for treating sterile inflammation |
12/15/2010 | CN101912612A Dispersible tablet containing fibrate and statin drug and application thereof |
12/15/2010 | CN101912611A Drug composition with anti-tumor effect |
12/15/2010 | CN101564536B Sustained and controlled release preparation for pharmaceutical composition for curing hypertension |
12/15/2010 | CN101267837B Compositions for treatment of systemic mastocytosis |
12/15/2010 | CN101254181B Hypertension-treating medicine combination |
12/15/2010 | CN101138635B Fibrin glue vasodilation agent sustained-release long-acting composition |
12/15/2010 | CN101031321B Perorally administrable antimicrobial composition |
12/14/2010 | USRE41996 Composition and methods for enhancing receptor-mediated cellular internalization |
12/14/2010 | US7851607 Expression vector comprising nucleotide sequences coding porcine reproductive and respiratory syndrome polypeptide for use in generating vaccine to prevent viral infection; immunotherapy |
12/14/2010 | US7851592 Recombinant check point kinase for use in identifying modulator for use in treatment and prevention of cell proliferative disorders |
12/14/2010 | US7851586 Peptides for activation and inhibition of δPKC |
12/14/2010 | US7851458 Cartilage enhancing food supplements and methods of preparing the same |
12/14/2010 | US7851447 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve |
12/14/2010 | US7850999 For therapy of psoriasis, eczema, ichthyosis, pruritus, dryness and dermatitis, which may cause skin to crack, chap or chafe |
12/14/2010 | US7850995 having a cationic surfactant adsorbed on their surfaces to provide superior adhesion to a biological substrate, e.g., an insect, teeth, bone, nails, chitin, feathers, plants, mucous, skin; drug delivery |
12/14/2010 | US7850990 Compositions for delivery of drug combinations |